Phyllis B. Malpas

Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision

C. London, P. Bergman, J. Boucher, 2009, Clinical Cancer Research.

Risk assessment of microcystin in dietary Aphanizomenon flos-aquae.

L. Barton, D. Schaeffer, P. B. Malpas, 1999, Ecotoxicology and environmental safety.

In Vitro Drug-Drug Interaction Screens for Canine Veterinary Medicines: Evaluation of Cytochrome P450 Reversible Inhibition

C. Locuson, Divesh Aidasani, M. J. Zaya, 2008, Drug Metabolism and Disposition.

Clinical development of estrogen modulators for breast cancer chemoprevention in premenopausal vs. postmenopausal women

C. Sigman, G. Kelloff, J. Lawrence, 2000, Journal of cellular biochemistry. Supplement.

The pharmacokinetics of oclacitinib maleate, a Janus kinase inhibitor, in the dog.

J. Boucher, W. Collard, M. Stegemann, 2014, Journal of veterinary pharmacology and therapeutics.

In Vitro Drug-Drug Interaction Screens for Canine Veterinary Medicines: Evaluation of Cytochrome P450 Reversible Inhibition

C. Locuson, Divesh Aidasani, M. J. Zaya, 2008, Drug Metabolism and Disposition.